Am J Surg

1. SARFRAZ A, Khalil M, Rashid Z, Altaf A, et al
   Racial/ethnic and socioeconomic disparities in cancer mortality hotspots: A multi-state geospatial analysis.
   Am J Surg. 2025;248:116492.
   

   >> Share

   
   
2. WOODS AL, Kachen A, Dejenie RA, Flynn SM, et al
   Time to definitive treatment in rectal cancer care coordination.
   Am J Surg. 2025;248:116333.
   

   >> Share

   
   

   
   Ann Surg

3. LI K, Li H, Wu A, Zang L, et al
   Long-Term Survival on Extent of Lymphadenectomy for Right-Sided Colon Cancer: Five-Year Follow-up Results of a Randomized Controlled Trial (RELARC Trial).
   Ann Surg. 2025 Sep 12. doi: 10.1097/SLA.0000000000006941.
   

   >> Share

   
   

   
   Ann Surg Oncol

4. OCHIAI K, Bhutiani N
   The Evolving Multidisciplinary Management of Retroperitoneal Lymph Node Metastases from Colorectal Cancer.
   Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18321.
   

   >> Share

   
   

   
   Br J Surg

5. TAIEB J, Karoui M
   Challenges of decision-making after treatment with immunotherapy in metastatic deficient DNA mismatch repair/microsatellite unstable colorectal cancer.
   Br J Surg. 2025;112:znaf178.
   

   >> Share

   
   

   
   Eur J Surg Oncol

6. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
   Rethinking TNM: Tumor deposit-based prognostic models may improve N-staging in colorectal cancer.
   Eur J Surg Oncol. 2025;51:110420.
   

   >> Share

   
   
7. XIAO J, Gu C, Wu Q, Yang X, et al
   Feasibility of ambulatory colectomy in the tertiary hospital with surveillance in the community hospital: A propensity score-matched study.
   Eur J Surg Oncol. 2025;51:110077.
   

   >> Share

   
   
8. CREEMERS DMJ, Mens DM, Nordkamp S, Piqeur F, et al
   Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort.
   Eur J Surg Oncol. 2025;51:110261.
   

   >> Share

   
   
9. NG JC, Sassun R, Sileo A, Violante T, et al
   Real-world clinical outcomes of total neoadjuvant therapy followed by total mesorectal excision for locally advanced rectal cancer at a high-volume institution.
   Eur J Surg Oncol. 2025;51:110181.
   

   >> Share

   
   
10. HAQ MU, Pritchard DM, Hughes DM, Javed MA, et al
    Long-term outcomes of patients treated with contact X-ray brachytherapy and external beam (chemo)radiotherapy following local excision of rectal adenocarcinoma.
    Eur J Surg Oncol. 2025;51:110216.
    

    >> Share

    
    
11. NOIRET B, Koo CH, Bacci M, Lamichhane NB, et al
    Clinical contexts for Shared Decision-Making in rectal cancer: Organ preservation, sphincter-sparing surgery and tailored stoma policy.
    Eur J Surg Oncol. 2025;51:110196.
    

    >> Share

    
    
12. MENS DM, Coebergh van den Braak RRJ, Hilling DE, Meyer V, et al
    Nationwide analysis on the role of neoadjuvant radiotherapy and watch and wait in rectal cancer.
    Eur J Surg Oncol. 2025;51:110179.
    

    >> Share

    
    
13. MENS DM, van Rees JM, Husson O, Crolla RMPH, et al
    Impact of minimal invasive surgery techniques on long-term health-related quality of life in rectal cancer: a Dutch cohort study.
    Eur J Surg Oncol. 2025;51:110180.
    

    >> Share

    
    
14. KEFLEYESUS A, Bakrin N, Kepenekian V, Gerbaud-Coulas C, et al
    Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility.
    Eur J Surg Oncol. 2025;51:110150.
    

    >> Share

    
    

    
    Gut

15. BAATRUP G, Bjorsum-Meyer T, Kaalby L, Schelde-Olesen B, et al
    Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial.
    Gut. 2025;74:1616-1623.
    

    >> Share

    
    
16. RUTTER MD, Ranjan R, Westwood C, Barbour J, et al
    BSG/ACPGBI guidance on the management of colorectal polyps in patients with limited life expectancy.
    Gut. 2025;74:1551-1560.
    

    >> Share

    
    
17. CUI Y, Liu H, Zhang L, Zhang H, et al
    Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells.
    Gut. 2025 Sep 11:gutjnl-2025-335014. doi: 10.1136/gutjnl-2025-335014.
    

    >> Share

    
    

    
    Int J Cancer

18. POTTHOFF K, Uhlig J, Jacobasch L, Muller L, et al
    Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VA
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70139.
    

    >> Share

    
    

    
    Int J Colorectal Dis

19. AFRIDI A, Zulfiqar A, Sajjad F, Shahid I, et al
    Efficacy and safety of indocyanine green fluorescence imaging in colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.
    Int J Colorectal Dis. 2025;40:193.
    

    >> Share

    
    
20. NASSAR A, Aly NE, Elhusseini M, Parnaby C, et al
    Outcomes of the management of synchronous rectal and prostate cancer: a systematic review.
    Int J Colorectal Dis. 2025;40:195.
    

    >> Share

    
    

    
    Int J Oncol

21. COSTABILE V, Duraturo F, Delrio P, Rega D, et al
    [Corrigendum] Lithium chloride induces mesenchymal?to?epithelial reverting transition in primary colon cancer cell cultures.
    Int J Oncol. 2025;67:94.
    

    >> Share

    
    

    
    J Am Coll Surg

22. MYERS S, Davis ES, Murillo A, Ng SC, et al
    Surgical Approach as a Mediator of Rural-Urban Disparity after Colon Cancer Resection.
    J Am Coll Surg. 2025 Sep 10. doi: 10.1097/XCS.0000000000001601.
    

    >> Share

    
    

    
    J Clin Oncol

23. BEITER ER, Patel SR, Chen CT
    Immunotherapy Efficacy in Mismatch Repair-Proficient Colorectal Cancer Patients With and Without Liver Metastases.
    J Clin Oncol. 2025 Sep 11:JCO2501044. doi: 10.1200/JCO-25-01044.
    

    >> Share

    
    

    
    Mol Ther Oncol

24. RIO-VILARINO A, Garcia-Bautista A, Cenigaonandia-Campillo A, Mateos-Gomez PA, et al
    Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer.
    Mol Ther Oncol. 2025;33:201032.
    

    >> Share

    
    

    
    Oncogene

25. REN Y, Chen J, Zhan X, Sheng S, et al
    Correction: Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism.
    Oncogene. 2025 Sep 10. doi: 10.1038/s41388-025-03540.
    

    >> Share

    
    
26. TRAN TQ, Duysak T, Kim K, Dang GC, et al
    Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella.
    Oncogene. 2025;44:3449-3460.
    

    >> Share

    
    

    
    PLoS One

27. WANG J, Li J, Huo J, Zhao Y, et al
    Correction: Fibrinogen and colorectal cancer: A study of the Chinese population.
    PLoS One. 2025;20:e0332402.
    

    >> Share

    
    
28. BIE AKL, Handberg Juul Martiny F, Jauernik CP, Rahbek OJ, et al
    Physical harms in colorectal cancer screening: An overview of the reporting in systematic reviews and randomised controlled trials.
    PLoS One. 2025;20:e0331104.
    

    >> Share

    
    
29. ZHU M, Wang X, Zhang D, Chen A, et al
    Global, regional, and national burdens of five main digestive system cancers in adolescents and young adults from 1990 to 2021 based on the Global Burden of Disease Study 2021: A cross-sectional study.
    PLoS One. 2025;20:e0329377.
    

    >> Share

    
    
30. ROUHOLLAHI MR, Aghili M, Nemati S, Mohagheghi MA, et al
    "Colorectal Cancer Care Quality in a Developing Country: Insights from a Comparison of Teaching and Non-teaching Hospitals in Iran".
    PLoS One. 2025;20:e0326796.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share